<DOC>
	<DOCNO>NCT00600327</DOCNO>
	<brief_summary>The primary objective study demonstrate safety NexStent treatment carotid artery lesion undergo stenting adjunctive use FilterWire distal embolic protection device . The rate compare Objective Performance Criterion ( OPC ) derive historic data high-risk patient undergo surgical intervention Carotid endarterectomy . Patients include study high risk complication associate CEA .</brief_summary>
	<brief_title>Carotid Artery Revascularization Using Boston Scientific EPI Filter Wire EZ™ EndoTex™ NexStent™</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<criteria>patient great equal 18 year age . Anticipated patient life expectancy least one year date index procedure . Lesion locate common carotid artery ( CCA ) and/or internal carotid artery ( ICA ) carotid bifurcation . Target vessel vessel treat intervention lesion less equal 30 mm treat single stent . Vessel treat 4.0 mm 9.0 mm diameter . Patient either symptomatic asymptomatic ; Symptomatic : Stenosis must great equal 50 % determined angiogram patient history stroke , TIA and/or amaurosis fugax hemisphere supply target vessel within 180 day procedure . Patient either symptomatic asymptomatic ; Asymptomatic : Stenosis must great equal 60 % determine angiogram without neurological symptom . Distal vessel `` land zone '' placement FilterWire must 3.5 mm 5.5 mm diameter visual angiographic recommendation describe IFU . Female patient childbearing potential document negative pregnancy test ( urine blood ) within 10 day index procedure . Patient ( legal guardian ) understand nature procedure provide sign informed consent use form review approved Investigational Review Board/Ethics Committee respective clinical site prior procedure . This obtain prior participation study . Patient willing comply protocol requirement return treatment center require clinical evaluation Patient must fulfill least one follow Class I : Unstable angina , LVEF le 30 % , CHF class III class IV , dialysis dependent renal failure , severe COPD , requirement stag CABG valve replacement post carotid index procedure , Previous carotid endarterectomy significant restenosis , total occlusion contralateral carotid artery , Previous radiation treatment neck radical neck dissection , Target lesion second vertebral body C2 clavicle , Inability extend head due cervical arthritis cervical disorder , Tracheostomy tracheal stoma , Presence laryngeal nerve palsy , Bilateral carotid artery stenosis determine angiography . If patient meet Class I criteria , patient must meet two follwing class II criterion : Patient great equal 75 year age , Myocardial infarction within previous 6 week , Requires stag peripheral vascular surgery ( i.e . abdominal aortic aneurysm repair ) major surgery post carotid index procedure , Two proximal major diseased coronary artery great equal 70 % stenosis revascularized . Previously place stent target vessel . Total occlusion target vessel ( ICA CCA ) . Angiographically visible thrombus . Carotid string sign ( tiny , long segment contrast true lumen artery , aneurysmal pouch formation , distal location arteriopathy ) poor visualization distal vessel . Vertebrobasilar insufficiency symptom , without clearly identifiable symptom referable targeted carotid artery . Vessel anatomy preclude use stent system distal protection system . Presence carotid artery dissection . Requirement stag CABG , valve replacement abdominal aortic aneurysm procedure 30 day index procedure . Evidence major disable stroke within previous 30 day . Patient evolve stroke experience major stroke ( NIHSS score great equal 15 ) within 3 month . History intracranial hemorrhage within past 12 month . Any condition precludes proper angiographic assessment make percutaneous arterial access unsafe , e.g . morbid obesity , history chronic hypertension control medical therapy . Contraindication heparin , aspirin , clopidogrel ( Plavix® ) , Xray contrast ticlopidine ( Ticlid® ) case intolerance clopidogrel . History liver failure elevate prothrombin time . History current indication bleed diathesis coagulopathy . Hgb &lt; 8 gm/dl ( unless dialysis ) , platelet count &lt; 50,000 , WBC &gt; 15,000 , INR &gt; l.5 ( irreversible ) heparinassociated thrombocytopenia . Known cardiac source emboli treatment anticoagulant therapy . Atherosclerotic disease involve adjoin vessel preclude safe placement guide catheter sheath . Planned treatment nontarget lesion within 30 day . Other abnormal angiographic finding indicate patient risk stroke due problem target lesion , : ipsilateral arterial stenosis great severity target lesion , cerebral aneurysm , arteriovenous malformation ( AVM ) cerebral vasculature . Dementia confusion . The patient enrol another study protocol . Patient may participate another investigational trial 12 month postindex procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Stroke</keyword>
	<keyword>thrombosis</keyword>
	<keyword>thromboembolic</keyword>
	<keyword>Transient Ischemic Attack</keyword>
	<keyword>TIA</keyword>
</DOC>